Is bone marrow trephine biopsy necessary in multiple myeloma patients at diagnosis?
Ver/ Abrir
Registro completo
Mostrar el registro completo DCAutoría
Gea, Ana; Fernández, Tatiana; Fernández Luis, Sara; Domínguez García, Juan José; Francés, Irene; Tobalina, Ana; Cantera, Rodrigo; Bannatyne, Julia; Gorostidi, Irene; Oviedo, María; Cerezo, Juan M.; García, Raquel; Insunza Gaminde, Andrés; Montes Gaisán, Carmen María; Bermúdez, Aránzazu; Montes Moreno, Santiago

Fecha
2025-04Derechos
© 2025. This manuscript version is made available under the CC-BY-NC-ND 4.0 license
Publicado en
Clinical Lymphoma, Myeloma & Leukemia, 2025, 25(4), e210-e213
Editorial
Elsevier
Disponible después de
2026-05-01
Enlace a la publicación
Palabras clave
Bone marrow
Aspirate
Multiple myeloma
Resumen/Abstract
Multiple myeloma (MM) diagnosis requires 10% plasma cell (PC) infiltration in the bone marrow (BM), detected by bone marrow aspiration (BMA) or biopsy (BMB). We evaluated the concordance of these 2 techniques in 189 patients. In 43 cases (23%), the techniques were discordant, 10 due to poor sample quality. In the remaining 33 patients, BMB diagnosed MM, while BMA detected < 10% PC, being symptomatic in 16 patients and smouldering (SMM) in 17. Without an initial BMB, 11% would have been misdiagnosed; and 12% of symptomatic patients would require a second BMA or BMB for strict diagnosis according to current criteria.
Colecciones a las que pertenece
- D22 Artículos [1134]